According to Holly F
Lancet Diabetes endocrinol (2021) 9(10):65362
In general, oral therapies are associated with improved convenience acceptance and compliance by patients, particularly when taking additional medications, as is often the case in the management of diabetes
Supplementary information Rights and permissions Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material
In response, branded manufacturers such as Lilly and Novo Nordisk have launched consumer-facing initiatives to reinforce the safety, efficacy, and regulatory oversight of FDA-approved products